tiprankstipranks
Trending News
More News >
Thiogenesis Therapeutics Corp (TSE:TTI)
:TTI
Canadian Market

Thiogenesis Therapeutics Corp (TTI) Income Statement

Compare
3 Followers

Thiogenesis Therapeutics Corp Income Statement

Last quarter (Q3 2024), Thiogenesis Therapeutics Corp's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Thiogenesis Therapeutics Corp's net income was $-656.86K. See Thiogenesis Therapeutics Corp’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Feb 22Feb 21Dec 20
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ ―$ ―$ ―$ ―$ ―
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ ―$ ―$ ―$ ―
EBITDA
$ -5.06M$ -3.92M$ -224.43K$ -92.65K$ -473.55K
Operating Income
$ -5.21M$ -4.02M$ -224.68K$ -92.65K$ -473.39K
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -5.06M$ -3.92M$ -224.46K$ -92.68K$ -476.30K
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Thiogenesis Therapeutics Corp Earnings and Revenue History